Paris, France

Philippe Vayron

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2013-2016.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Philippe Vayron: Innovator in Chemical Synthesis

Introduction

Philippe Vayron is a prominent inventor based in Paris, France. He has made significant contributions to the field of chemical synthesis, holding a total of 7 patents. His work focuses on innovative methods for preparing complex chemical compounds.

Latest Patents

Among his latest patents is a method for preparing 5-amino-benzoyl-benzofuran derivatives. This invention relates to a method that involves hydrogenating a 5-nitro-benzofuran derivative in the presence of palladized charcoal as a catalyst. The resulting compounds are valuable in various chemical applications. Another notable patent is a process for preparing sulfonamidobenzofuran derivatives. This process involves coupling a benzofuran derivative with a sulfonamide derivative, utilizing a catalyst system formed from a palladium compound and a ligand.

Career Highlights

Philippe Vayron is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry. His expertise in chemical synthesis has contributed to advancements in drug development and formulation.

Collaborations

Philippe has collaborated with notable colleagues, including Xavier Bon and Julia Mateos-Caro. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Philippe Vayron's contributions to chemical synthesis and his innovative patents highlight his role as a key figure in the field. His work continues to influence advancements in pharmaceuticals and chemical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…